Skip to main content
ConductScienceScienceDex

John Sfakianos

NIH Rank #6252
Unclaimed recordClaim profile
  • R01 Holder
  • Translational
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 11490783Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Genetics
  • Urology

NIH Funding · FY2026

Linked Award Amount
$1.4M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#6,252
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for John Sfakianos. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing John Sfakianos as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA301050-02R01
    Multi-scale analysis of Bacillus Calmette-Guérin (BCG) resistant tumor micro-environment in non-muscle invasive bladder cancer to identify novel therapeutic axis
    Icahn School of Medicine at Mount Sinai
    $683.3K
    award amount
  • 5R01CA269954-04R01
    HLA-E and NKG2A define a novel immune checkpoint axis in non-muscle-invasive bladder cancer
    Icahn School of Medicine at Mount Sinai
    $667.2K
    award amount

Award organization

Organizations that administered FY2026 awards listing John Sfakianos as a PI.

FY2026 award administered by Icahn School of Medicine at Mount Sinai (NY).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Icahn School of Medicine at Mount Sinai
  2. 2024
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding
  5. 2025
    R01 Grant Holder
  6. 2026
    Entered Top 50% Nationally
    Ranked #6252

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as John Sfakianos.

Amir Horowitz
Icahn School of Medicine at Mount Sinai
6
shared awards
Won-min Song
Icahn School of Medicine at Mount Sinai
2
shared awards

Explore further

Find collaborators for John Sfakianos

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →